Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Qian Qi
CONTACT
Lead
Qianfoshan Hospital
Subjects who have been identified to have severe asthma with ABPA will be consented and enrolled in the study to receive Tezepelumab injections (210 mg subcutaneous) administered every 4 weeks.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
